Prostate-Specific Antigen Velocity for Early Detection of Prostate Cancer: Result from a Large, Representative, Population-based Cohort Academic Article uri icon

Overview

MeSH Major

  • Early Detection of Cancer
  • Mass Screening
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • In men with PSA of about ≥3 ng/ml, we found little justification for formal calculation of PSAV or for use of PSAV cut points to determine biopsy. Informal assessment of PSAV will likely aid clinical judgment, such as a sudden rise in PSA suggesting prostatitis, which could be further evaluated before biopsy.

publication date

  • November 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2891354

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2009.07.047

PubMed ID

  • 19682790

Additional Document Info

start page

  • 753

end page

  • 60

volume

  • 56

number

  • 5